Literature DB >> 15543612

Expression and prognostic value of lactoferrin mRNA isoforms in human breast cancer.

Monique Benaïssa1, Jean-Philippe Peyrat, Louis Hornez, Christophe Mariller, Joël Mazurier, Annick Pierce.   

Abstract

We investigated the expression levels of human lactoferrin (Lf), a steroid hormone-inducible gene product the expression of which is often altered during oncogenesis, and of Delta-lactoferrin (DeltaLf), its alternative isoform, which has been shown to be absent from tumor cell lines in commonly used human breast epithelial cell lines, using semiquantitative RT-PCR. Both mRNAs were detected but with levels of expression lower than those found in normal breast epithelial cells. This downregulation was much more visible for DeltaLf since its expression was either significantly diminished (BT-20, MCF-7 cell lines) or practically absent (MDA-MB-231, T-47D, HBL 100 cell lines). In order to determine whether Lf gene products are useful prognosic tools, we further analyzed their expression levels in 99 primary breast cancer biopsies. DeltaLf transcripts were found in all of the samples, whereas Lf transcripts were found in 88% of them. Lf and DeltaLf expression levels were positively correlated (p = 0.003). Lf expression was related to tumor type with a higher recovery in lobular-type tumors (p = 0.04). DeltaLf expression was related to the histoprognostic grading (p = 0.02). In univariate analyses, DeltaLf and Lf expressions were prognosis parameters, high concentrations being associated with a longer overall survival. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15543612     DOI: 10.1002/ijc.20728

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Does lactoferrin behave as an immunohistochemical oncofetal marker in bone and cartilage human neoplasms?

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Giuseppe Speciale; Michele A Rosa; Giovanni Tuccari
Journal:  Pathol Oncol Res       Date:  2010-10-24       Impact factor: 3.201

2.  Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.

Authors:  Antonio Ieni; Valeria Barresi; Luana Licata; Roberta Cardia; Carmine Fazzari; Giuseppe Nuciforo; Francesco Caruso; Michele Caruso; Vincenzo Adamo; Giovanni Tuccari
Journal:  Oncol Lett       Date:  2017-03-14       Impact factor: 2.967

3.  O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin.

Authors:  Stéphan Hardivillé; Esthelle Hoedt; Christophe Mariller; Monique Benaïssa; Annick Pierce
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

4.  Lactoferrin-Decorated Cerium Oxide Nanoparticles Prevent Renal Injury and Fibrosis.

Authors:  Mohd Aslam Saifi; Rishabh Hirawat; Chandraiah Godugu
Journal:  Biol Trace Elem Res       Date:  2022-05-14       Impact factor: 3.738

Review 5.  Cellular iron metabolism in prognosis and therapy of breast cancer.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Crit Rev Oncog       Date:  2013

6.  Lactoferrin immuno-expression in human normal and neoplastic bone tissue.

Authors:  Antonio Ieni; Valeria Barresi; Maddalena Grosso; Michele Attilio Rosa; Giovanni Tuccari
Journal:  J Bone Miner Metab       Date:  2009-02-26       Impact factor: 2.626

7.  Growth differentiation factor-15 and lactoferrin immuno-expression in breast cancer: relationship with body iron-status and survival outcome.

Authors:  Zheng Zhang; Hao-Jie Jiang; Huan-Huan Yang; Jin-Jin Ren; Guo-Qin Jiang; Jia-Ying Xu; Li-Qiang Qin
Journal:  Biometals       Date:  2021-01-23       Impact factor: 2.949

8.  Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathway.

Authors:  Magdalena Cizkova; Géraldine Cizeron-Clairac; Sophie Vacher; Aurélie Susini; Catherine Andrieu; Rosette Lidereau; Ivan Bièche
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

9.  Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

Authors:  Stefano Calza; Per Hall; Gert Auer; Judith Bjöhle; Sigrid Klaar; Ulrike Kronenwett; Edison T Liu; Lance Miller; Alexander Ploner; Johanna Smeds; Jonas Bergh; Yudi Pawitan
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

10.  Genome-wide pathway analysis reveals different signaling pathways between secreted lactoferrin and intracellular delta-lactoferrin.

Authors:  Byungtak Kim; Seongeun Kang; Sun Jung Kim
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.